Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiachen Zou
Observed name:
Jia‐chen Zou
Institutions:
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University
Observed institutions:
Guangdong Medical College,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University,
Guangzhou Medical University
ORCID:
0000-0003-0483-3803
Observed ORCID:
0000-0003-0483-3803
OpenAlex ID:
A5077413554
Clinical efficacy of tumor organoid‐guided cancer therapy for locally advanced unresectable or metastatic breast cancer
2024
·
Ying‐yi Lin
, Hong‐fei Gao
, et al.
·
International Journal of Cancer
·
20
Homologous Recombination Deficiency Predicts Response to Platinum-Based Neoadjuvant Chemotherapy in Early-Stage Triple-Negative Breast Cancer Patients: A Systematic Review and Meta-Analysis
2021
·
Liulu Zhang
, Yuanqi Chen
, et al.
·
Therapeutic Advances in Medical Oncology
·
17
PDF
18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer
2023
·
Xingxing Zheng
, Yuhong Huang
, et al.
·
EJNMMI Research
·
13
PDF
Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy With Immunotherapy Result in Different Tumor Shrinkage Patterns in Triple-Negative Breast Cancer
2023
·
Jiachen Zou
, Liulu Zhang
, et al.
·
Journal of Breast Cancer
·
11
Case report: solitary splenic metastasis occurring 19 months after primary treatment for occult breast cancer
2022
·
Yuanqi Chen
, Liulu Zhang
, et al.
·
Frontiers in Oncology
·
4
PDF
Multimodal nomogram for predicting axillary pathological complete response after neoadjuvant therapy in clinically node-positive breast cancer
2026
·
Minyi Cheng
, Jieqing Li
, et al.
·
Frontiers in Oncology
·
1
PDF
Magnetic resonance imaging tumor regression shrinkage patterns during neoadjuvant chemotherapy versus neoadjuvant immunochemotherapy in triple-negative breast cancer (NeoMDSS-TN-SP): A nonrandomized, prospective cohort study.
2023
·
Liulu Zhang
, Jiachen Zou
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
7
Citation count:
66
H-index:
4
I10-index:
4
Year
Topic
Type